| - GRCh37:
- Chr6:32010726
- GRCh38:
- Chr6:32042949
| LOC106780803, TNXB | | Ehlers-Danlos syndrome due to tenascin-X deficiency | Likely pathogenic (Jun 6, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32037581
- GRCh38:
- Chr6:32069804
| TNXB | G1779E | Ehlers-Danlos syndrome due to tenascin-X deficiency | Uncertain significance (May 7, 2021) | criteria provided, single submitter |
| | TNXB | | Ehlers-Danlos syndrome due to tenascin-X deficiency | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr6:32036406
- GRCh38:
- Chr6:32068629
| TNXB | T1994I | Ehlers-Danlos syndrome due to tenascin-X deficiency, Vesicoureteral reflux 8 | Uncertain significance (Mar 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32036856
- GRCh38:
- Chr6:32069079
| TNXB | P1882L | Vesicoureteral reflux 8, Ehlers-Danlos syndrome due to tenascin-X deficiency | not provided | no assertion provided |
| - GRCh37:
- Chr6:32049423-32049424
- GRCh38:
- Chr6:32081646-32081647
| TNXB | R1255fs | Vesicoureteral reflux 8, Ehlers-Danlos syndrome due to tenascin-X deficiency | Pathogenic/Likely pathogenic (May 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32065945
- GRCh38:
- Chr6:32098168
| TNXB | S11C | Ehlers-Danlos syndrome due to tenascin-X deficiency | Likely pathogenic (Jun 30, 2022) | no assertion criteria provided |
| - GRCh37:
- Chr6:32047074
- GRCh38:
- Chr6:32079297
| TNXB | E1371K | Inborn genetic diseases | Uncertain significance (Jul 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32046965
- GRCh38:
- Chr6:32079188
| TNXB | K1407R | Ehlers-Danlos syndrome due to tenascin-X deficiency | Uncertain significance (Aug 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32010281
- GRCh38:
- Chr6:32042504
| LOC106780803, TNXB | R4052P, R4054P, R483P | Ehlers-Danlos syndrome due to tenascin-X deficiency | Uncertain significance (Aug 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32063845
- GRCh38:
- Chr6:32096068
| TNXB | S595R | Ehlers-Danlos syndrome due to tenascin-X deficiency | Uncertain significance (Apr 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32047017
- GRCh38:
- Chr6:32079240
| TNXB | L1390V | Ehlers-Danlos syndrome due to tenascin-X deficiency | Uncertain significance (Feb 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32062902-32062910
- GRCh38:
- Chr6:32095125-32095133
| TNXB | | Ehlers-Danlos syndrome due to tenascin-X deficiency | Uncertain significance (Feb 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32063824
- GRCh38:
- Chr6:32096047
| TNXB | D602E | Ehlers-Danlos syndrome due to tenascin-X deficiency | Uncertain significance (Feb 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32017140
- GRCh38:
- Chr6:32049363
| TNXB | G3220R, G3222R | Cardiovascular phenotype, Ehlers-Danlos syndrome due to tenascin-X deficiency | Conflicting interpretations of pathogenicity (Nov 7, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:32056820
- GRCh38:
- Chr6:32089043
| TNXB | D841N | Ehlers-Danlos syndrome due to tenascin-X deficiency | Uncertain significance (Oct 29, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32039874
- GRCh38:
- Chr6:32072097
| TNXB | R1628Q | not provided, Ehlers-Danlos syndrome due to tenascin-X deficiency, Cardiovascular phenotype
| Uncertain significance (May 23, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32010470
- GRCh38:
- Chr6:32042693
| LOC106780803, TNXB | | not provided, Vesicoureteral reflux 8, Ehlers-Danlos syndrome due to tenascin-X deficiency
| Likely benign (Apr 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32056638
- GRCh38:
- Chr6:32088861
| TNXB | | Cardiovascular phenotype, Vesicoureteral reflux 8, Ehlers-Danlos syndrome due to tenascin-X deficiency
| Uncertain significance (Dec 21, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32062915
- GRCh38:
- Chr6:32095138
| TNXB | R766W | Vesicoureteral reflux 8, Ehlers-Danlos syndrome due to tenascin-X deficiency | Uncertain significance (Feb 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32025841
- GRCh38:
- Chr6:32058064
| TNXB | V2607I | Vesicoureteral reflux 8, Ehlers-Danlos syndrome due to tenascin-X deficiency | Uncertain significance (Feb 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32036778
- GRCh38:
- Chr6:32069001
| TNXB | F1908Y | Cardiovascular phenotype, Vesicoureteral reflux 8, Ehlers-Danlos syndrome due to tenascin-X deficiency
| Uncertain significance (Jun 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32036590
- GRCh38:
- Chr6:32068813
| TNXB | | Vesicoureteral reflux 8, Ehlers-Danlos syndrome due to tenascin-X deficiency | Uncertain significance (Mar 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32029328
- GRCh38:
- Chr6:32061551
| TNXB | K2446N | Ehlers-Danlos syndrome due to tenascin-X deficiency | not provided | no assertion provided |
| - GRCh37:
- Chr6:32063891
- GRCh38:
- Chr6:32096114
| TNXB | Y580C | Cardiovascular phenotype, Ehlers-Danlos syndrome due to tenascin-X deficiency, Vesicoureteral reflux 8
| Uncertain significance (Oct 11, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32009655-32009656
- GRCh38:
- Chr6:32041878-32041879
| LOC106780803, TNXB | N4174fs, N4176fs, N605fs | Ehlers-Danlos syndrome due to tenascin-X deficiency | Uncertain significance (Dec 23, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32032606
- GRCh38:
- Chr6:32064829
| TNXB | G2278V | Cardiovascular phenotype, Vesicoureteral reflux 8, Ehlers-Danlos syndrome due to tenascin-X deficiency, not provided | Uncertain significance (Apr 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32021483
- GRCh38:
- Chr6:32053706
| TNXB | E2825K | Ehlers-Danlos syndrome due to tenascin-X deficiency, Vesicoureteral reflux 8 | Likely pathogenic (Feb 22, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32065767
- GRCh38:
- Chr6:32097990
| TNXB | Q70R | Cardiovascular phenotype, Ehlers-Danlos syndrome, Vesicoureteral reflux 8, Ehlers-Danlos syndrome due to tenascin-X deficiency, not provided | Uncertain significance (Dec 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32065134
- GRCh38:
- Chr6:32097357
| TNXB | T166P | not provided | Uncertain significance (Jan 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32025877
- GRCh38:
- Chr6:32058100
| TNXB | E2595K | Vesicoureteral reflux 8, Ehlers-Danlos syndrome due to tenascin-X deficiency, Cardiovascular phenotype, not provided | Uncertain significance (Nov 15, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32029933
- GRCh38:
- Chr6:32062156
| TNXB | | Cardiovascular phenotype, Ehlers-Danlos syndrome due to tenascin-X deficiency | Conflicting interpretations of pathogenicity (Apr 1, 2020) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:32029207
- GRCh38:
- Chr6:32061430
| TNXB | R2487C | not provided, Cardiovascular phenotype, Ehlers-Danlos syndrome due to tenascin-X deficiency
| Uncertain significance (Dec 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32064182-32064367
- GRCh38:
- Chr6:32096405-32096590
| TNXB | | Cardiovascular phenotype, not provided | Uncertain significance (Dec 8, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32023706
- GRCh38:
- Chr6:32055929
| TNXB | G2797W | Ehlers-Danlos syndrome due to tenascin-X deficiency | Uncertain significance (Feb 22, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32041621
- GRCh38:
- Chr6:32073844
| TNXB | T1495I | Cardiovascular phenotype, Ehlers-Danlos syndrome, Ehlers-Danlos syndrome due to tenascin-X deficiency, Vesicoureteral reflux 8, not provided | Benign/Likely benign (Jul 22, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32025910
- GRCh38:
- Chr6:32058133
| TNXB | R2584C | Vesicoureteral reflux 8, Ehlers-Danlos syndrome due to tenascin-X deficiency, Cardiovascular phenotype, not provided, Ehlers-Danlos syndrome | Conflicting interpretations of pathogenicity (Mar 30, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:32024560
- GRCh38:
- Chr6:32056783
| TNXB | T2649M | Cardiovascular phenotype, not provided, Ehlers-Danlos syndrome due to tenascin-X deficiency, Vesicoureteral reflux 8 | Uncertain significance (Jul 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32056840-32056842
- GRCh38:
- Chr6:32089063-32089065
| TNXB | | Ehlers-Danlos syndrome due to tenascin-X deficiency, Vesicoureteral reflux 8, not provided
| Benign (Nov 29, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32008963
- GRCh38:
- Chr6:32041186
| CYP21A2, TNXB | | Ehlers-Danlos syndrome due to tenascin-X deficiency, Vesicoureteral reflux 8, not provided
| Benign (Aug 9, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32037475
- GRCh38:
- Chr6:32069698
| TNXB | D1814E | Cardiovascular phenotype, Ehlers-Danlos syndrome, not provided, Ehlers-Danlos syndrome due to tenascin-X deficiency, Vesicoureteral reflux 8 | Benign/Likely benign (Aug 27, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32035679
- GRCh38:
- Chr6:32067902
| TNXB | | Cardiovascular phenotype, Ehlers-Danlos syndrome, not provided, Ehlers-Danlos syndrome due to tenascin-X deficiency, Vesicoureteral reflux 8 | Conflicting interpretations of pathogenicity (Mar 8, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:32036176
- GRCh38:
- Chr6:32068399
| TNXB | G2071R | Cardiovascular phenotype, Ehlers-Danlos syndrome, not provided, Ehlers-Danlos syndrome due to tenascin-X deficiency, Vesicoureteral reflux 8 | Uncertain significance (Jul 6, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32049426
- GRCh38:
- Chr6:32081649
| TNXB | P1254R | Cardiovascular phenotype, Ehlers-Danlos syndrome, not provided, Ehlers-Danlos syndrome due to tenascin-X deficiency, Vesicoureteral reflux 8 | Uncertain significance (Nov 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32065863
- GRCh38:
- Chr6:32098086
| TNXB | R38Q | Ehlers-Danlos syndrome, Ehlers-Danlos syndrome due to tenascin-X deficiency, Vesicoureteral reflux 8, Cardiovascular phenotype, not provided | Benign/Likely benign (Sep 13, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32052409
- GRCh38:
- Chr6:32084632
| TNXB | D1076N | Cardiovascular phenotype, Vesicoureteral reflux 8, Ehlers-Danlos syndrome, not provided, Ehlers-Danlos syndrome due to tenascin-X deficiency, Vesicoureteral reflux 8
| Conflicting interpretations of pathogenicity (Jul 14, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:32017346
- GRCh38:
- Chr6:32049569
| TNXB | P3151R, P3153R | Cardiovascular phenotype, Ehlers-Danlos syndrome due to tenascin-X deficiency, Vesicoureteral reflux 8, not provided | Uncertain significance (Nov 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32053892
- GRCh38:
- Chr6:32086115
| TNXB | S928Y | Cardiovascular phenotype, Vesicoureteral reflux 8, Ehlers-Danlos syndrome, Ehlers-Danlos syndrome due to tenascin-X deficiency, Vesicoureteral reflux 8, not provided
| Uncertain significance (Jun 13, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32021489
- GRCh38:
- Chr6:32053712
| TNXB | | Ehlers-Danlos syndrome, not provided, Vesicoureteral reflux 8, Ehlers-Danlos syndrome due to tenascin-X deficiency | Conflicting interpretations of pathogenicity (Oct 23, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:32037426
- GRCh38:
- Chr6:32069649
| TNXB | V1831M | not provided, Cardiovascular phenotype | Uncertain significance (Feb 16, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32057130
- GRCh38:
- Chr6:32089353
| TNXB | | Vesicoureteral reflux 8, Ehlers-Danlos syndrome due to tenascin-X deficiency, Cardiovascular phenotype, not provided | Likely benign (Jan 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32010227
- GRCh38:
- Chr6:32042450
| LOC106780803, TNXB | | Vesicoureteral reflux 8, Ehlers-Danlos syndrome due to tenascin-X deficiency, not provided
| Likely benign (Sep 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32030051
- GRCh38:
- Chr6:32062274
| TNXB | G2351R | not provided, Vesicoureteral reflux 8, Ehlers-Danlos syndrome due to tenascin-X deficiency, Cardiovascular phenotype | Benign/Likely benign (May 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32049177
- GRCh38:
- Chr6:32081400
| TNXB | R1337H | Ehlers-Danlos syndrome, not provided, Vesicoureteral reflux 8, Ehlers-Danlos syndrome due to tenascin-X deficiency, Cardiovascular phenotype | Uncertain significance (Jun 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32064134
- GRCh38:
- Chr6:32096357
| TNXB | G499D | Vesicoureteral reflux 8, Ehlers-Danlos syndrome due to tenascin-X deficiency, not provided, Cardiovascular phenotype | Uncertain significance (Jul 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32016423
- GRCh38:
- Chr6:32048646
| TNXB | | Vesicoureteral reflux 8, Ehlers-Danlos syndrome due to tenascin-X deficiency, Ehlers-Danlos syndrome, Cardiovascular phenotype, not provided | Benign/Likely benign (Mar 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32017224
- GRCh38:
- Chr6:32049447
| TNXB | D3192N, D3194N | Vesicoureteral reflux 8, Ehlers-Danlos syndrome due to tenascin-X deficiency, Cardiovascular phenotype, not provided | Uncertain significance (Aug 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32065890
- GRCh38:
- Chr6:32098113
| TNXB | R29Q | Vesicoureteral reflux 8, Ehlers-Danlos syndrome due to tenascin-X deficiency, Ehlers-Danlos syndrome, not provided, Cardiovascular phenotype | Benign/Likely benign (Mar 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32064150
- GRCh38:
- Chr6:32096373
| TNXB | T494S | Cardiovascular phenotype, not provided | Uncertain significance (May 15, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32025858
- GRCh38:
- Chr6:32058081
| TNXB | P2601L | Vesicoureteral reflux 8, Ehlers-Danlos syndrome due to tenascin-X deficiency, not provided, Cardiovascular phenotype | Conflicting interpretations of pathogenicity (May 6, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:32032634
- GRCh38:
- Chr6:32064857
| TNXB | Q2269* | not provided | Likely pathogenic (Oct 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32009589
- GRCh38:
- Chr6:32041812
| LOC106780803, TNXB | A4196T, A4198T, A627T | not provided, Vesicoureteral reflux 8, Ehlers-Danlos syndrome due to tenascin-X deficiency
| Likely benign (Apr 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32063547
- GRCh38:
- Chr6:32095770
| TNXB | R695W | Vesicoureteral reflux 8, Ehlers-Danlos syndrome due to tenascin-X deficiency, Inborn genetic diseases, not provided | Uncertain significance (Sep 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32029253
- GRCh38:
- Chr6:32061476
| TNXB | | Vesicoureteral reflux 8, Ehlers-Danlos syndrome due to tenascin-X deficiency, Cardiovascular phenotype, not provided | Benign/Likely benign (Dec 30, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32025956
- GRCh38:
- Chr6:32058179
| TNXB | | Vesicoureteral reflux 8, Ehlers-Danlos syndrome due to tenascin-X deficiency, not provided, Cardiovascular phenotype | Benign/Likely benign (Sep 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32021325
- GRCh38:
- Chr6:32053548
| TNXB | Q2875H, Q2877H | not provided, Cardiovascular phenotype, Vesicoureteral reflux 8, Ehlers-Danlos syndrome due to tenascin-X deficiency | Uncertain significance (Aug 25, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32010461
- GRCh38:
- Chr6:32042684
| LOC106780803, TNXB | | Vesicoureteral reflux 8, Ehlers-Danlos syndrome due to tenascin-X deficiency, not provided
| Likely benign (May 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32036363
- GRCh38:
- Chr6:32068586
| TNXB | | Cardiovascular phenotype, not provided, Vesicoureteral reflux 8, Ehlers-Danlos syndrome due to tenascin-X deficiency | Benign/Likely benign (Sep 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32053864
- GRCh38:
- Chr6:32086087
| TNXB | | Vesicoureteral reflux 8, Ehlers-Danlos syndrome due to tenascin-X deficiency, Ehlers-Danlos syndrome, Cardiovascular phenotype, not provided | Conflicting interpretations of pathogenicity (Jun 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:32053641
- GRCh38:
- Chr6:32085864
| TNXB | V1012I | Ehlers-Danlos syndrome due to tenascin-X deficiency, Vesicoureteral reflux 8, not provided, Cardiovascular phenotype, Ehlers-Danlos syndrome | Conflicting interpretations of pathogenicity (Feb 23, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:32056594
- GRCh38:
- Chr6:32088817
| TNXB | V916A | Ehlers-Danlos syndrome due to tenascin-X deficiency | Uncertain significance (Dec 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32020490
- GRCh38:
- Chr6:32052713
| TNXB | H3022Q, H3024Q | Ehlers-Danlos syndrome due to tenascin-X deficiency | Uncertain significance (Aug 1, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32064842
- GRCh38:
- Chr6:32097065
| TNXB | R263H | not provided, Cardiovascular phenotype, Ehlers-Danlos syndrome due to tenascin-X deficiency
| Uncertain significance (Feb 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32036632
- GRCh38:
- Chr6:32068855
| TNXB | H1957Y | Ehlers-Danlos syndrome due to tenascin-X deficiency | Uncertain significance (Jun 29, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32039896
- GRCh38:
- Chr6:32072119
| TNXB | V1621M | not provided, Cardiovascular phenotype, Ehlers-Danlos syndrome due to tenascin-X deficiency
| Uncertain significance (Apr 25, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32037555
- GRCh38:
- Chr6:32069778
| TNXB | T1788fs | Ehlers-Danlos syndrome due to tenascin-X deficiency | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr6:32065068
- GRCh38:
- Chr6:32097291
| TNXB | P188S | Ehlers-Danlos syndrome due to tenascin-X deficiency, Vesicoureteral reflux 8, Cardiovascular phenotype
| Uncertain significance (Oct 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32065689
- GRCh38:
- Chr6:32097912
| TNXB | L96H | Ehlers-Danlos syndrome due to tenascin-X deficiency, Vesicoureteral reflux 8 | Uncertain significance (Mar 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32035662
- GRCh38:
- Chr6:32067885
| TNXB | S2107C | Ehlers-Danlos syndrome due to tenascin-X deficiency | Uncertain significance (Feb 4, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32026114
- GRCh38:
- Chr6:32058337
| TNXB | A2516T | Cardiovascular phenotype, Ehlers-Danlos syndrome due to tenascin-X deficiency | Uncertain significance (Apr 3, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32012194
- GRCh38:
- Chr6:32044417
| LOC106780803, TNXB | D172N, D3741N, D3743N | Ehlers-Danlos syndrome, Ehlers-Danlos syndrome due to tenascin-X deficiency | Uncertain significance (Aug 28, 2020) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32037429
- GRCh38:
- Chr6:32069652
| TNXB | S1830R | Cardiovascular phenotype, not provided, Ehlers-Danlos syndrome due to tenascin-X deficiency, Inborn genetic diseases, Ehlers-Danlos syndrome | Conflicting interpretations of pathogenicity (Mar 15, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:32050061
- GRCh38:
- Chr6:32082284
| TNXB | G1163E | Ehlers-Danlos syndrome, Vesicoureteral reflux 8, not provided, Cardiovascular phenotype, Ehlers-Danlos syndrome due to tenascin-X deficiency | Uncertain significance (May 26, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32023663
- GRCh38:
- Chr6:32055886
| TNXB | R2811Q | Ehlers-Danlos syndrome, not provided, Cardiovascular phenotype, Ehlers-Danlos syndrome due to tenascin-X deficiency | Conflicting interpretations of pathogenicity (Jul 13, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:32018002
- GRCh38:
- Chr6:32050225
| TNXB | A3069V, A3071V | not provided, Vesicoureteral reflux 8, Ehlers-Danlos syndrome due to tenascin-X deficiency, Cardiovascular phenotype | Uncertain significance (Nov 19, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32021195
- GRCh38:
- Chr6:32053418
| TNXB | V2919M, V2921M | Cardiovascular phenotype, Vesicoureteral reflux 8, not provided, Vesicoureteral reflux 8, Ehlers-Danlos syndrome due to tenascin-X deficiency | Conflicting interpretations of pathogenicity (Apr 30, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:32046976
- GRCh38:
- Chr6:32079199
| TNXB | | Cardiovascular phenotype, not provided, Vesicoureteral reflux 8, Ehlers-Danlos syndrome due to tenascin-X deficiency | Likely benign (Jan 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32032790
- GRCh38:
- Chr6:32065013
| TNXB | P2217T | Cardiovascular phenotype, Ehlers-Danlos syndrome, not provided, Ehlers-Danlos syndrome due to tenascin-X deficiency | Conflicting interpretations of pathogenicity (May 4, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:32053673
- GRCh38:
- Chr6:32085896
| TNXB | P1001L | Ehlers-Danlos syndrome due to tenascin-X deficiency, not provided | Uncertain significance (Oct 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32012921
- GRCh38:
- Chr6:32045144
| LOC106780803, TNXB | P26S, P3595S, P3597S | Ehlers-Danlos syndrome due to tenascin-X deficiency | Uncertain significance (Apr 8, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32029976
- GRCh38:
- Chr6:32062199
| TNXB | G2376C | Ehlers-Danlos syndrome due to tenascin-X deficiency | Uncertain significance (Jan 1, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32063460
- GRCh38:
- Chr6:32095683
| TNXB | R724C | Cardiovascular phenotype, Ehlers-Danlos syndrome due to tenascin-X deficiency, Ehlers-Danlos syndrome due to tenascin-X deficiency, Vesicoureteral reflux 8, Ehlers-Danlos syndrome, not provided
| Conflicting interpretations of pathogenicity (May 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:32064769
- GRCh38:
- Chr6:32096992
| TNXB | | Cardiovascular phenotype, Ehlers-Danlos syndrome due to tenascin-X deficiency, Vesicoureteral reflux 8
| Conflicting interpretations of pathogenicity (Apr 7, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:32052423
- GRCh38:
- Chr6:32084646
| TNXB | T1071R | Cardiovascular phenotype, Ehlers-Danlos syndrome due to tenascin-X deficiency, Vesicoureteral reflux 8
| Uncertain significance (Nov 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32037501
- GRCh38:
- Chr6:32069724
| TNXB | F1806L | not provided, Ehlers-Danlos syndrome due to tenascin-X deficiency, Vesicoureteral reflux 8
| Uncertain significance (Apr 24, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32036210
- GRCh38:
- Chr6:32068433
| TNXB | H2059Q | Cardiovascular phenotype, not provided, Ehlers-Danlos syndrome due to tenascin-X deficiency, Vesicoureteral reflux 8 | Uncertain significance (Jul 18, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32013077
- GRCh38:
- Chr6:32045300
| LOC106780803, TNXB | E3543K, E3545K | Ehlers-Danlos syndrome due to tenascin-X deficiency, Vesicoureteral reflux 8 | Uncertain significance (Mar 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:32023909
- GRCh38:
- Chr6:32056132
| TNXB | E2729G | Cardiovascular phenotype, not provided, Ehlers-Danlos syndrome due to tenascin-X deficiency, Vesicoureteral reflux 8 | Uncertain significance (Mar 24, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:32024650
- GRCh38:
- Chr6:32056873
| TNXB | P2619L | Cardiovascular phenotype, Inborn genetic diseases, Ehlers-Danlos syndrome, not provided, Ehlers-Danlos syndrome due to tenascin-X deficiency | Conflicting interpretations of pathogenicity (Jun 20, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:32029249
- GRCh38:
- Chr6:32061472
| TNXB | R2473C | Cardiovascular phenotype, not provided, Ehlers-Danlos syndrome due to tenascin-X deficiency, Vesicoureteral reflux 8 | Benign/Likely benign (Jul 19, 2021) | criteria provided, multiple submitters, no conflicts |